It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2018
  5. Busulfex Injection 60mg Approved in Japan for Once-Daily Administration in Adults

September 25, 2018

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

Busulfex Injection 60mg Approved in Japan for Once-Daily Administration in Adults

Otsuka Pharmaceutical Co., Ltd. today announces it has received regulatory approval for a once-daily form of Busulfex® Injection 60 mg (generic name is busulfan). Busulfex is a conditioning regimen administered via intravenous drip to patients prior to undergoing hematopoietic stem cell transplantation.


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases